BrightSpring Health Services to Expand with Divested Assets from Amedisys & UnitedHealth, Eyes Continued Growth in In-Home Primary Care
BrightSpring Health Services, a leading provider of home- and community-based health solutions, is poised for important expansion. the company plans to finalize the acquisition of divested assets from Amedisys and UnitedHealth (through its former subsidiary, LHC Group) in the fourth quarter of this year. This move underscores BrightSpring’s commitment to serving complex populations with integrated care.
Key Takeaways:
* Strategic Acquisition: BrightSpring is acquiring assets primarily from Amedisys, with a smaller portion originating from LHC Group, which UnitedHealth acquired in 2023.
* Financial Impact: The deal is expected to be accretive to BrightSpring’s earnings starting in 2026.
* Growth Focus: The company continues to prioritize growth in in-home primary care, alongside its existing pharmacy, home health, and behavioral health services.
* Strong Q3 Performance: BrightSpring reported robust Q3 2025 results,with revenue reaching $3.334 billion – a 28.2% year-over-year increase.
Expanding Footprint Through Strategic Acquisitions
The acquisition comes as Amedisys and UnitedHealth navigate regulatory requirements following recent mergers and divestitures. While LHC Group was acquired by UnitedHealth,the assets BrightSpring is acquiring largely stem from Amedisys. According to BrightSpring President and CEO Jon rousseau, the initial focus was on amedisys branches, but the scope slightly increased as UnitedHealth finalized agreements with the Federal Trade Commission (FTC).
“There’s always been some of the domestic branches for LHC, but it’s been the minority,” Rousseau explained during the company’s Q3 earnings call. “I think we’ve just more or less said Amedisys in the past.”
This acquisition allows BrightSpring to further solidify its position as a national leader in home-based care. You can expect a seamless integration of these assets, enhancing BrightSpring’s ability to reach and serve more individuals in need.
In-Home primary Care: A Core Growth Strategy
BrightSpring isn’t just focused on expanding where it provides care, but how. The company views in-home primary care as a major growth opportunity, particularly when combined with its existing suite of services.
As Rousseau noted, ”We believe primary care at home remains a large opportunity as we continue to build out the business, particularly as it relates to the benefits of our integrated services.”
This integrated approach – combining pharmacy, home health, primary care, and behavioral health – allows BrightSpring to manage patient outcomes more effectively and improve cash flow. It’s a strategy that’s resonating with investors, as evidenced by recent funding rounds for other in-home primary care providers:
* Nest Health: Secured $12.5 million in August, focusing on Medicaid-eligible patients.
* Gather Health: Raised $21 million in July, offering a hybrid in-home and in-clinic model.
These investments demonstrate the growing recognition of the value proposition of bringing primary care directly to patients’ homes.
Q3 2025 Performance Highlights
BrightSpring’s strong Q3 2025 financial results demonstrate the effectiveness of its growth strategies. Here’s a closer look:
* Total Revenue: $3,334 million (up 28.2% year-over-year)
* Provider Revenue: Increased 9% year-over-year, with home health care accounting for approximately 50% of this revenue.
* Home Health Revenue: $188 million (up 12% year-over-year) – driven by quality metrics, patient satisfaction, operational investments, expansion, and Medicare Advantage contracts.
* Home Health Daily Census: 29,592 (up 3% year-over-year)
* Personal Care Census: 16,134 (up 1% year-over-year)
These figures highlight BrightSpring’s ability to consistently deliver growth across its core business segments.
Looking Ahead: Core & Strategic Growth
BrightSpring’s leadership team is focused on